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32Objective: Fibrocollagen-covered polyester meshes can be used as possible substitutions for tracheal segments if
they become integrated into the tissue without complications. The aim of this study was to assess a fibrocollagen-
covered polyester prosthesis to be used as a substitution for a tracheal segment.
Methods: We performed a blind, randomized experimental assay. Adult Wistar rats were assigned to one of 2
groups. Prostheses were made by implanting polyester tubing in a group of animals to cover them with homol-
ogous collagen. They were implanted as substitutions of tracheal segments in the experimental group after cre-
ating a defect in the anterior wall of the trachea. Clinical, histomorphologic, and immunohistochemical
assessments were made at 4 different time points.
Results: The experimental group presented some respiratory distress signs during the first 7 to 10 days, such as
stertors, hissing, and low motor activity. After this initial period, the symptoms subsided progressively and dis-
appeared at the end of the first month. These respiratory symptoms caused no mortality. Initially undifferentiated
monolayer cells predominated on the implant’s surface, but during the last 2 months, the proportion of epithelial
and ciliated cells was similar to that seen in control animals. Types I, III, and V collagen fibers were identified
around the mesh. The intraluminal area of the tracheas with prostheses and prosthesis thickness were larger during
the 4 months of the experiment. The increase in thickness was due to angiogenesis without evidence of fibrosis or
chronic inflammation.
Conclusions: Polyester-collagen prostheses used as substitutions of tracheal segments in rats enabled the prolif-
eration of normal respiratory epithelium and maintained tracheal function without collapse, inflammatory reac-
tion, or secondary stenosis. (J Thorac Cardiovasc Surg 2010;139:32-7)When permanent tracheal injuries are present,1-3 resection of
the damaged area and tracheal restitution with an end-to-end
anastomosis have been considered the gold standard of surgi-
cal treatment.4 Unfortunately, this is not always possible. The
risk of inducing complications results from ignoring limits
that should not be exceeded.5-7 Establishment of the func-
tional lumen in the trachea is the objective of a wide array
of reconstructive techniques used to date.8,9 Among them,
tracheal replacement has been attempted with solid or porous
prostheses. Some porous9 prostheses can be covered with
collagen; collagen is a modulator of the extracellular matrix
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The Journal of Thoracic and Cardiovascular SurgeThe purpose of this work was to assess the efficacy and
compatibility of a fibrocollagen-covered polyester mesh, ob-
tained from a donor of the same species as replacement of
a noncircumferential segment from the anterior side of the
cervical trachea.
MATERIALS AND METHODS
The Research and Ethics Committees of the Instituto Nacional de Pedia-
trı´a reviewed and approved the research protocol (June 2005). All animals
were cared for according to the recommendations of the laboratory animal
care guide formulated by the National Society for Medical Research, ‘‘The
guide for the care and use of laboratory animals’’ (National Institutes of
Health publication no. 85-23, revised 1985), and the Official Mexican Stan-
dard NOM-062-ZOO-1999. Male adult Wistar rats weighing 250 to 400 g
from the animal facilities of the Research Division of the Instituto Nacional
de Pediatrı´a were used.
Forty rats were assigned a consecutive number, and the groups to be used
as donors and recipients of the prosthesis, as well as the animals not under-
going operations (the control group), were assigned by a simple drawing of
numbers. The donor group comprised 8 animals. The experimental and con-
trol groups were each constituted by 4 subgroups of 4 rats each, which cor-
responded to follow-up time (ie, 1, 2, 3, and 4 months).
Implantation and Surgical Procedures
The Eiken’s technique,12 as modified by Padilla-Sa´nchez and colleagues,13
was used to obtain the prosthesis. A 40-denier Celanese XRZ4 polyester mesh
(Celanese, Dallas, Tex) was used to cover silicon tubes (16F, 3-cm long;ry c January 2010
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PBS ¼ phosphate-buffered saline
RT ¼ room temperatureFIGURE 1. Mesh and Silastic (Dow Corning, Midland, Mich) tube before
subcutaneus insertion on the backs of the donor animals.Figure 1). The mesh-covered tubes were sterilized with 80%ethylene oxide for
24 hours and placed subcutaneously on the back of the donor animals by means
of an antiseptic surgical technique. After 4 weeks, the tubes were extracted and
immersed in Hank’s solution at 4C for 6 hours and then in a 0.5% glutaralde-
hyde solution for 15 days. Afterward, the fibrocollagenous tubes were washed
with a 0.9% saline solution for 45 minutes and cut into 1-cm-long sections to
obtain 2 fibrocollagen-covered tubes. The initial aim of this experiment was the
installation of the prostheses in a single surgical time period after removing
4 cartilage rings of the cervical trachea. However, the first 5 consecutive rats
presented severe dyspnea caused by the collapse of the tubular implant; these
animals died or were killed during the 12 postoperative hours to spare them
from further suffering. Based on this experience, we decided to implant these
tubes by using a sterile technique at the left external face of the trachea and
immediately underneath the second cervical cartilage, fixing them with a
6–0 Vicryl sutures (Ethicon, Inc, Somerville, NJ) in the 4 experimental groups.
The other groups did not undergo operations and served as the control group.
A month later, the experimental rats underwent reoperation. After
achievement of general anesthesia and using a sterile technique, through
an anterior incision and blunt dissection and avoiding separation of the pros-
thesis from the muscular mass and the lateral face of the trachea, the anterior
face of rings 2 to 6 was exposed, and at that level, a section of the tracheal
surface corresponding to 30% to 40% of the anterior diameter of the trachea
was resected. The produced defect was covered with the concave face of the
prosthesis, eliminating excess tissue from the borders, followed by suture to
the lips of the cartilage with 8 to 9 separated polypropylene stitches. After
finishing the anastomosis, the muscular planes were sutured with 4–0 Vicryl
sutures, and the skin was sutured with 4–0 Dermalon sutures (Covidien Ltd,
Mansfield, Mass). All surgical procedures were performed with a micro-
scope (Carl Zeiss, Essingen, Germany) and after achievement of general an-
esthesia with a mixture of 3 mg/kg xylazine, 35 mg/kg ketamine, and 0.05
mg/kg atropine sulphate applied intramuscularly.
Postsurgical Follow-up
After the surgical procedure, the animals were housed in individual cages in
a temperature-controlled environment and under a 12-hour/12-hour light/dark
schedule. Animals were given water and food (LabDiet; Purina Mills,
St Louis, Mo) ad libitum. During the immediate postoperative period, 4 ses-
sions of micronebulization with budesonide (250 mg/2 mL) were applied at
12-hour intervals; enrofloxacine (5 mg/kg) and metamizol (25 mg/kg admin-
istered intramuscularly) were administered for 3 consecutive days. On the
fourth day, oxytetracycline (10 mg/mL of water) was administered for 10 days.
Clinical Assessment
Each group was followed independently for 1, 2, 3, or 4 months, respec-
tively, during which the presence of respiratory distress, hissing, stertors,
mucosal cyanosis, hypoactivity, or death was monitored and registered ev-
ery day. At the end of the observation period, rats were killed with a lethal
sodium pentobarbital dose (60 mg/kg) and perfused transcardially for 3 min-
utes with phosphate-buffered saline (PBS), pH 3.4, and for 30 minutes with
a 4% paraformaldehyde and 2.5% glurataraldehyde solution (0.1 mol/L
PBS, pH 7.4). The tracheas were coded for blind analysis.
Specimen Processing for Electron Transmission
Microscopy
The trachea was dissected by using a surgical microscope at the level of
the implant, and 4 to 5 transversal segments of approximately 2-mm thick-The Journal of Thoracic and Cness were obtained. The specimens were postfixed in 2% osmium tetroxide,
dehydrated by means of ethanol series, and embedded in epoxy resin. Mor-
phologic analysis was performed on semithin sections (0.5 mm) stained with
toluidine blue. We determined the area, total length of the implant, and the
zone with or without cilia in each section. Morphometric analysis was per-
formed with a Zeiss Axioscop-2 Plus microscope coupled to an image sys-
tem analysis system, AxioVision version 4.4 (Carl Zeiss). Proximal zones to
the suture stitches of the implant with the trachea and from the central part of
the implant were taken from a transversal section of the trachea from each rat
and group to assess the characteristics of the epithelium that developed on
the implant. These samples were then re-embedded in Epon. From these
samples, 60 to 90-mm sections were obtained, placed on grids, and con-
trasted with uranyl acetate/lead citrate. The samples were analyzed with
a Carl Zeiss EM-109 transmission electron microscope. We obtained con-
tiguous micrographs from each sample, and approximately 12 mm of each
zone was reconstructed. The type and number of cells were determined
on the basis of cellular morphology, as described by Cross and Mercer.14
In regions with undifferentiated cells, the number of nuclei was considered
as the number of cells undergoing differentiation.
Immunohistochemical Method
Paraffin-embedded sections. The tracheas of the control and ex-
perimental rats were collected at necropsy and longitudinally sectioned at
the middle line (through the prosthesis in experimental rats), and approxi-
mately 0.5-cm-long fragments were fixed with 10% buffered neutral forma-
lin for 24 hours and then processed with paraffin embedding and sectioning.
Tracheal tissue sections of 6 to 8 mm in thickness were obtained, mounted on
poly-L-lysine–coated slides, and stained with Masson’s trichrome stain for
collagen determination, mainly type I fibers; Wilder’s method for reticulum
fibers or type III collagen fibers; and alcian blue, pH 2.5, for weakly acidic
sulfated glycosaminoglycans and hyaluronan, according to protocols from
the Armed Forces Institute of Pathology.15 The purpose was to identify
the extracellular matrix components of connective tissue associated to the
prosthesis.
Immunohistochemical procedures. Tracheal sections for im-
munohistochemistry were mounted on positive-charged slides (Superfrost
plus; Shandon, Inc, Pittsburgh, Pa), deparaffinized with xylene, rehydrated
with PBS, and then transferred to plastic Coplin jars containing 0.1 mol/L
citrate buffer (pH 6.0) for antigen retrieval treatment, as described by Shi
and associates.16 In brief, slides were heated inside the Coplin jars, which
were placed in a pressure cooker for 20 minutes at the highest temperature
of a hot plate (approximately 200C) and 10 minutes more at an intermedi-
ate temperature (approximately 100C). Afterward, slides were maintained
in the Coplin jars for 15 minutes at room temperature (RT) and then trans-
ferred to 0.15 mol/L PBS, pH 7.2, until required.ardiovascular Surgery c Volume 139, Number 1 33
FIGURE 2. Tracheal cross-section reconstruction 4 months after implant-
ing the prosthesis: note the deformed tracheal contour. (Toluidine blue;
Original magnification 103.) The inset shows ciliated pseudostratified co-
lumnar epithelium and capillaries in the submucosa. (Original magnification
403.) C, Capillary cartilage. Arrows indicate glands.
FIGURE 3. Deformation of the tracheal contour evidencing the thickness
of the implant wall without affecting the lumen. The posterior wall, consti-
tuted by the noncartilaginous portion of the trachea, is contracted. (Original
magnification 403.)
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SAfter antigen retrieval, endogenous peroxidase was inhibited by means
of incubation in 3% hydrogen peroxide diluted in methanol for 30 minutes
at RT. Slides were then incubated for 1 hour at RT in PBS–2% bovine se-
rum albumin–0.01% Triton X-100 solution to reduce nonspecific back-
ground staining, followed by overnight incubation at 4C with primary
antibodies specific for rat fibrillar collagen type I (goat polyclonal IgG;
Santa Cruz Biotechnology, Inc, Santa Cruz, Calif) or type V (mouse mono-
clonal antibody IgG; Chemicon International, Temecula, Calif) diluted
1:100 in PBS–0.1% bovine serum albumin. After 3 washes in PBS, slides
were incubated in biotinylated anti-goat or anti-mouse IgG secondary anti-
body for 1 hour at RT, and then an avidin–biotin–horseradish peroxidase
complex was used, and the reaction was developed with 3030-diaminobenzi-
dine as chromogen, according to the supplier’s instructions (all reagents
were from Santa Cruz Biotechnology, Inc). Negative controls were tissue
sections processed as mentioned above but incubated with normal mouse
or normal goat sera as primary antibodies.
Statistical Analysis
Data were tabulated and analyzed with the Shapiro–Wilks test. Normally
distributed data were analyzed with the Student t test for independent sam-
ples, and the Mann–Whitney U test was used for nonnormally distributed
data. The possible differences between the control and experimental groups
at the 4 times of observation were assessed by means of ANOVA or the
Kruskal–Wallis test. The SPSS version 12 statistical package (SPSS, Inc,
Chicago, Ill) was used in the analyses.RESULTS
No deaths occurred, and the implanted rats presented few
cases of stertors, hissing, and low motor activity during the
first 7 to 10 days. Afterward, these distress signs disappeared
progressively and were nil at the end of the first month. After
killing the animals, at the time of necropsy, it was found that
the habitual circular morphology of the trachea had changed
at the site of the prosthesis, adopting different shapes, al-34 The Journal of Thoracic and Cardiovascular Surgethough 8 of the 16 presented a triangular contour with a pos-
terior vertex (Figures 2 and 3). The intraluminal area of the
trachea presented a normal distribution in both the control
and experimental groups. On comparison of the intraluminal
area (control vs experimental group), that of the control
group was 3.71  0.21 mm2 smaller than the experimental
areas at the 4 analyzed times: (1) 4.61  0.36 mm2, (2)
4.45  0.3 mm2, (3) 4.63  0.31 mm2, and (4) 4.25 
0.35 mm2 (P ¼ .05, Student t test). The thickness of the im-
planted wall, presenting a large dispersion and abnormal dis-
tribution at the 4 observation periods, was greater (ie, [1]
487.5  121.2 mm, [2] 721  274.8 mm, [3] 1061  275
mm, and [4] 1425 393 mm) than that of the control tracheal
wall (average of 388  82 mm; P ¼ .01; Figure 4). On the
surface of the implant, as well as in the control group, 4 types
of cells (globular, basal, undifferentiated, and ciliated) were
identified. However, during the first 2 months, undifferenti-
ated monolayer cells predominated in the experimental
group, but thereafter, the range and variety of epithelial cells
were similar to those of the control group (Table 1). The
amount of ciliated cells over the prosthesis oscillated from
0% in the first month to 94% and 95% in the last 2 months,
respectively (Table 2 and Figure 5).
Histologic analysis showed that the increased thickness of
the implant was due to the presence of abundant bloodry c January 2010
FIGURE 4. Thickness of the tracheal wall 3 months after implantation. The labeled line indicates the thickness in micrometers from the mucosa (muc) to the
adventitia (adv). A, Control group; B, experimental group. The arrow shows the fibrocollagen-covered polyester mesh. We found abundant capillaries (C).
(Toluidine blue; original magnification 103.)
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gen fibers (probably types I and III) adhering to and surround-
ing the mesh. A scanty positive stain to glycosaminoglycans
and hyaluronan covered the surface of the mesh. Immunohis-
tochemistry corroborated that collagen types I and V were
components of the implant’s connective tissue matrix (Fig-
ure 6). Control results were negative.
Surprisingly, very few multinucleated giant cells and
small mononuclear infiltrates were observed. However,
mast cells were a frequent component of the implant (data
not shown).
The prostheses from the rats that died or were initially
killed were not subjected to histologic analyses because,
given the short time that elapsed between surgical interven-
tion and death, we expected to find no changes other than
those derived from the surgical trauma.DISCUSSION
The main concern after tracheal prosthetic repair is an un-
successful tracheal function caused by inadequate structural
support. De Ugarte and coworkers17 achieved the required
rigidity without collapse to repair a partial circumferentialTABLE 1. Range and number of epithelial cells per field in the
prostheses and their respective controls at 4 evaluated time points
Implant group
Cell Control group Month 1 Month 2 Month 3 Month 4
Ciliated 4–6 0 1–2 4–6 5–6
Globose 2–5 0 1 2–3 3
Basal 3–5 0 0 4 4–5
Undifferentiated 0 8–9 5–7 0 0
The Journal of Thoracic and Ctracheal defect by increasing the layer folds of a prosthesis
made of collagen-based matrix derived from porcine small
intestinal submucosa. After 4 weeks, this author observed
complete epithelization and neovascularization of the tra-
cheal patch. Nevertheless, most of the rats presented with
chronic and moderate inflammation, and the long-term abil-
ity to prevent scar contracture and restenosis was not evalu-
ated.
Collagen, particularly types I and III, induces angiogene-
sis, a phenomenon repeatedly observed in other studies in
which collagen fiber tunnels or conduits have been used,
with or without specific inducers.10,11,18,19 In this experi-
ment we assume that angiogenesis contributed to the in-
crease in tracheal wall thickness at the implant site, which
probably increased the structural support of the collagen-
covered mesh, thus avoiding its collapse.
Angiogenesis is a constituent of diverse natural processes,
such as placental formation and healing of wounds,20-22 or of
pathologic conditions, such as ischemia,20 diabetic retinop-
athy,23 and is found particularly in neoplasms24-28; signifi-
cant demands of oxygen and nutrients by the cells must be
satisfied during these processes. In this study the use of
fibrocollagen-covered prostheses from donors of the sameTABLE 2. Proportion of cilia-covered epithelium at 4 evaluation times
Time with
prosthesis (mo)
Total implant
zone (mm)
Cells covered
with cilia (%)
1 2.1  0.57 0
2 2.0  0.2 7
3 2.2  0.2 94
4 1.95  0.1 95
ardiovascular Surgery c Volume 139, Number 1 35
FIGURE 5. Micrograph of the mucosa at 1, 2, and 4 months after implantation. On the surface of the implant, we found undifferentiated cells at 1 month,
serous-like and undifferentiated cells at 2 months, and the same types of cells as found in the control group at 3 and 4 months. GC, Goblet cell; CC, ciliated
cells; BC, basal cells; SC, some serous-like cells.
FIGURE 6. Histology and immunohistochemistry of a fibrocollagen-cov-
ered prosthesis for segmental tracheal replacement in a rat. Collagen stain-
ing with either Masson’s trichrome stain (A) or Wilder’s method (B)
demonstrated the presence of a layer of collagen (blue and pink fibers,
respectively) already interwoven into the mesh and surrounding it. More-
over, black fibers corresponding to reticular fibers or type III collagen
(B) were a prominent component of the connective tissue matrix of the
mesh. Hyaluronan and glycosaminoglycans were also observed as a blue
stain over the mesh (C). Immunohistochemistry for type I (D and E) and
type V (F) collagen (dark brown stain) confirmed the histologic findings
of collagen staining. Note the presence of numerous blood vessels near
the mesh (A). (Original magnification: A, B, and F, 1003; C and E,
2003; D, 403.)
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Sspecies probably improved implant acceptance, and there-
fore in the absence of other adverse events, such as persistent
inflammation, foreign body reaction, and local infection, the
observed angiogenesis could be part of a repair and tissue in-
tegration process. On the other hand, there was no scar re-
traction, and the intraluminal area of the trachea was larger
in the experimental group than in the control group. How-
ever, this last effect was fortuitously achieved when cover-
ing the created space with the implant, which generated
a larger space because of the immediate retraction of the
remnant dissected cartilaginous rings, modifying the tra-
cheal contour at that level (Figure 3).
Growth of the respiratory epithelium from the borders of
the implant to the rest of its surface is another important ob-
jective. Davenport and Nettshein,10,11 in diverse experimen-
tal studies, proved that collagen is an excellent modulator of
extracellular matrix and a growth facilitator for the pseudos-
tratified epithelium.
In the present study evidence of ciliated respiratory epithe-
lium in the whole graft surface was observed after the second
month, probably because of the greater surface to be covered.
It can be assumed that the lack of ciliated cells, which was
particularly marked in the first few weeks, probably hindered
adequate management of secretions during the postoperative
period, accounting for the initially detected respiratory dis-
tress signs. However, the histologic findings from both light
and electron microscopy demonstrated an excellent incorpo-
ration of the homologous fibrocollagen-covered mesh into
the host tissue and the progressive regeneration of normal ep-
ithelial cells on the whole implant. The type of detected col-
lagen, aside from stimulating angiogenesis and growth of the
respiratory epithelium, probably eased the production, stor-
age, and release of chemical mediators, cytokines, growth
factors, and others as inducers of tissue repair.36 The Journal of Thoracic and Cardiovascular Surgery c January 2010
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STissue repair with a biocompatible substitute structure is
an old desire; however, this must ideally be free of leaks,
be noncollapsible, be tolerated by the host, show minimal
or no inflammatory reaction, and be impermeable to fibro-
blasts and bacterial invasion of the lumen, aside from being
able to cover the whole respiratory epithelium.29
Some of these objectives were met in this experiment.
However, to avoid the collapse of the implant, it was neces-
sary to reduce the size and to perform an extrasurgical proce-
dure to attach and stabilize it to the adjacent tracheal muscles
to facilitate local support. Other challenges for the future will
be to assess this type of prosthesis with autologous collagen,
particularly in young subjects, who we assume will accept it
more readily. To be able to apply this technique as a therapeu-
tic resource in pediatric patients, not only is immediate correc-
tion of the defect that originated the tissue substitution
warranted, but also the long-term effects during tracheal
growth along age must be addressed.
One of the most important clinical reports done recently is
the use of a bioprosthesis of Marlex mesh covered with a por-
cine collagen sponge, autologous blood, and additional sup-
port of polypropylene rings, which was applied successfully
for the first time in a 78-year-old woman. The implant was
not only well tolerated and integrated into the surrounding
tissues, but it also remained functional and without compli-
cations for 2 years after implantation.30 Reports such as
these enable us to assume that substitution of tracheal defects
with meshes made from diverse medical-use materials and
covered with collagen will, in the near future, be an addi-
tional alternative to the conventional or very sophisticated
tracheobronchial repair techniques.CONCLUSIONS
The polyester collagen prosthesis, used as a substitution
for a tracheal segment in rats, allowed normal functioning
without collapse and normal epithelization without chronic
inflammatory reaction or secondary tracheal stenosis. The
scientific, social, and economic effects of the use of
fibrocollagen-covered prostheses are very promising, but
research must be continued to improve these implants,
including models to be tested during specific growth stages,
because this can be a limiting factor.References
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